- Home
- TMP vs CERT Comparison
TMP vs CERT Comparison
Compare TMP & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TMP | CERT |
|---|---|---|
| Founded | 1836 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TMP | CERT |
|---|---|---|
| Price | $100.99 | $8.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $87.00 | $11.67 |
| AVG Volume (30 Days) | 83.7K | ★ 3.8M |
| Earning Date | 04-24-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | ★ 126.16 | 87.50 |
| EPS | ★ 3.86 | N/A |
| Revenue | $75,742,000.00 | ★ $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | $7.94 | $5.39 |
| P/E Ratio | $25.99 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $61.88 | $4.45 |
| 52 Week High | $102.02 | $13.88 |
Technical Indicators
Market Signals| Indicator | TMP | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 61.77 | 63.71 |
| Support Level | $91.10 | $6.15 |
| Resistance Level | $102.02 | $8.39 |
| Average True Range (ATR) | 2.27 | 0.40 |
| MACD | -0.17 | -0.03 |
| Stochastic Oscillator | 81.69 | 88.81 |
Price Performance
Historical ComparisonAbout TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.